Table 1.
The characteristics of included studies
| Author/year | Period | Study | Operation | Closure material | Stitch technique for suture group | Size | Age (mean) | SEX (male) | BMI | Closure length | Follow-up(days) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Staples | Sutures | Staples | Sutures | Staples | Sutures | Staples | Sutures | Staples | Sutures | |||||||||
| Khan/2006 | 2004 | RCT | THA |
3.0 poliglecaprone Suture, skin staples |
Subcutaneous continuous suture | 36 | 33 |
71 (33–78) |
69 (49–88) |
20/36 | 17/33 | 26.9 (21.1–38.9) | 27.7 (19.8–38.1) | 10.5 (7.5–22) | 10 (7.5–15) | 56–84 | ||
| Singh/2006 | 2001–2002 | RCT | THA, hemiarthroplasty |
Subcuticular vicryl skin clips |
Subcutaneous continuous suture | 17 | 17 | Unclear | Unclear | Unclear | Unclear | 2,5,7,10,14 | ||||||
| Buttaro/2015 | 2011–2012 | RCT | THA | 3.0 polypropylene suture, staples | Intradermal suture | 112 | 119 | 62 (range 21–91) | Unclear | Unclear | 12.2 (9–22) | 15,45 | ||||||
| Lu, Y/2018 | 2013–2015 | RC | THA, hemiarthroplasty | Nylon sutures, staples | interrupted suture | 111 | 141 |
64.1 (25–90) |
67.3 (22–99) |
53/111 | 56/141 | 24.4 (17.5–31.6) | 23.5 (14.9–20.6) | Unclear | 30 | |||
| Rui, M/2018 | 2014–2015 | RCT | THA |
4.0 absorbable subcuticular suture, staples |
Subcutaneous continuous suture | 83 | 82 |
55.7 (33–78) |
57.8 (35–79) |
36/83 | 39/82 | 27.1 (17.6–33.4) | 26.8 (16.4–32.2) | 13.8 (12–16) | 13.6 (12–15) | 90,365 | ||
| Mallee/2020 | 2012–2016 | RCT | THA | Absorbable suture or Donati-stitches, staples | Intradermal suture/interrupted suture | 268 | 267 |
70 (29–92) |
70 (38–90) |
182/268 | 175/267 | 28(18–48) | 27(17–46) | Unclear | 14,90,180,365 | |||
The characteristics of all included studies
RC: retrospective cohort; RCT: randomized controlled trial; THA: total hip arthroplasty